Johnson David Michael

Average Profitability
30.91%
Insider Buys Quantity
11
Insider Buys Sum
$1.7M
Insider Sells Quantity
3
Insider Sells Sum
$2.08M

Insider Activity of Johnson David Michael

According to the SEC Form 4 filings, Johnson David Michael, being in a position of

  1. director at Aura Biosciences, Inc.,
    оver the last 12 months, has bought 142601 share for $1.02M, and sold 0 shares,
    over all time since 2022-06-10, has bought 177967 shares for $1.39M, and sold 0 shares.

The largest purchase of all time was on 2023-11-07 and amounted to 123000 shares of Aura Biosciences, Inc. for $881,910.

The largest sale of all time was on 2021-10-04 and amounted to 12896 shares of Zentalis Pharmaceuticals, Inc. for $855,588.

Biography of Johnson David Michael

No biography is available at this moment.

2023-11-10PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
director
17,000
0.0243%
$9.88$167,943+18.55%
2023-11-08PurchaseAura Biosciences, Inc.
AURA
director
19,601
0.0517%
$7.30$143,087+11.25%
2023-11-07PurchaseAura Biosciences, Inc.
AURA
director
123,000
0.3185%
$7.17$881,910+12.66%
2023-10-04PurchaseAura Biosciences, Inc.
AURA
director
6,566
0.0178%
$8.61$56,512-7.88%
2023-10-03PurchaseAura Biosciences, Inc.
AURA
director
13,500
0.0352%
$8.27$111,663-6.59%
2023-01-06PurchaseAura Biosciences, Inc.
AURA
director
904
0.0024%
$10.51$9,501-3.81%
2023-01-05PurchaseAura Biosciences, Inc.
AURA
director
396
0.001%
$10.00$3,960-2.6%
2022-12-28PurchaseAura Biosciences, Inc.
AURA
director
2,000
0.0066%
$9.75$19,500+3.45%
2022-12-01PurchaseAura Biosciences, Inc.
AURA
director
5,000
0.0154%
$12.37$61,850-23.03%
2022-06-10PurchaseAura Biosciences, Inc.
AURA
7,000
0.0222%
$13.99$97,930-18.82%
2021-10-04SaleZentalis Pharmaceuticals, Inc.
ZNTL
director
12,896
0.0284%
$66.35$855,588-34.65%
2021-04-05SaleZentalis Pharmaceuticals, Inc.
ZNTL
director
12,897
0.0315%
$43.50$561,021+29.58%
2020-12-02SaleZentalis Pharmaceuticals, Inc.
ZNTL
director
12,896
0.0461%
$51.39$662,747+4.08%
2020-04-07PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
director
8,000
0.0176%
$18.00$144,000+70.78%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.